Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their ...

The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in ...

Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance ...

More and more people are taking weight loss injectables like Wegovy — but not everyone prescribed these drugs should have ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic, the drug that was originally approved to treat type 2 diabetes, has now also been approved by the FDA to reduce ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...